ABBV
AbbVie Inc.Company with tickers: ABBV
CIK
1551152
CUSIP
00287Y109
Shares Outstanding
1,766,792,821
13F Activity (30d)
1342 filings
1229 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so years a company never tagged show no figure.
Program Authorized
$10,000,000,000
as of 2018-02-15
Remaining Authorization
$1,800,000,000
as of 2026-03-31
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $980,000,000 | 10-K, filed 2026-02-20 |
| 2024-12-31 | $1,708,000,000 | 10-K, filed 2026-02-20 |
| 2023-12-31 | $1,972,000,000 | 10-K, filed 2026-02-20 |
| 2022-12-31 | $1,487,000,000 | 10-K, filed 2025-02-14 |
| 2021-12-31 | $934,000,000 | 10-K, filed 2024-02-20 |
| 2020-12-31 | $978,000,000 | 10-K, filed 2023-02-17 |
| 2019-12-31 | $629,000,000 | 10-K, filed 2022-02-18 |
| 2018-12-31 | $12,014,000,000 | 10-K, filed 2021-02-19 |
| 2017-12-31 | $1,410,000,000 | 10-K, filed 2020-02-21 |
| 2016-12-31 | $6,033,000,000 | 10-K, filed 2019-02-27 |
| 2015-12-31 | $7,586,000,000 | 10-K, filed 2018-02-16 |
| 2014-12-31 | $665,000,000 | 10-K, filed 2017-02-17 |
| 2013-12-31 | $320,000,000 | 10-K, filed 2016-02-19 |